- Home
- QSI vs BCX Comparison
QSI vs BCX Comparison
Compare QSI & BCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QSI
- BCX
- Stock Information
- Founded
- QSI 2013
- BCX 2011
- Country
- QSI United States
- BCX United States
- Employees
- QSI N/A
- BCX N/A
- Industry
- QSI Biotechnology: Pharmaceutical Preparations
- BCX Finance/Investors Services
- Sector
- QSI Health Care
- BCX Finance
- Exchange
- QSI Nasdaq
- BCX Nasdaq
- Market Cap
- QSI 633.2M
- BCX 745.8M
- IPO Year
- QSI N/A
- BCX N/A
- Fundamental
- Price
- QSI $2.24
- BCX $9.24
- Analyst Decision
- QSI Buy
- BCX
- Analyst Count
- QSI 2
- BCX 0
- Target Price
- QSI $3.25
- BCX N/A
- AVG Volume (30 Days)
- QSI 60.4M
- BCX 370.6K
- Earning Date
- QSI 02-27-2025
- BCX 01-01-0001
- Dividend Yield
- QSI N/A
- BCX 6.99%
- EPS Growth
- QSI N/A
- BCX N/A
- EPS
- QSI N/A
- BCX N/A
- Revenue
- QSI $2,266,000.00
- BCX N/A
- Revenue This Year
- QSI $193.90
- BCX N/A
- Revenue Next Year
- QSI $173.18
- BCX N/A
- P/E Ratio
- QSI N/A
- BCX N/A
- Revenue Growth
- QSI 232.26
- BCX N/A
- 52 Week Low
- QSI $0.61
- BCX $8.25
- 52 Week High
- QSI $5.77
- BCX $9.90
- Technical
- Relative Strength Index (RSI)
- QSI 49.02
- BCX 62.27
- Support Level
- QSI $1.85
- BCX $8.48
- Resistance Level
- QSI $2.68
- BCX $9.26
- Average True Range (ATR)
- QSI 0.83
- BCX 0.15
- MACD
- QSI -0.15
- BCX 0.08
- Stochastic Oscillator
- QSI 9.95
- BCX 93.83
About QSI Quantum-Si Incorporated
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.
About BCX BlackRock Resources of Beneficial Interest
BlackRock Resources & Commodities Strategy Trust operates as an investment trust. Its investment objective is to seek high current income and current gains, with a secondary objective of capital appreciation. The company invests at least 80% of its total assets in equity securities issued by commodity or natural resources companies, derivatives with exposure to commodity or natural resources companies or investments in securities and derivatives linked to the underlying price movement of commodities or natural resources.